Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

AMGEN INC.

THOUSAND OAKS, CA US

1. 20110045587 TOXIN PEPTIDE THERAPEUTIC AGENTS - DNA encoding a composition of matter of the formula 02-24-2011
2. 20110044986 ANTI-AMYLOID ANTIBODIES AND USES THEREOF 02-24-2011
3. 20110033472 Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof 02-10-2011
4. 20110021373 ANTIBODY CATEGORIZATION BASED ON BINDING CHARACTERISTICS 01-27-2011
5. 20110020811 HOST CELLS COMPRISING ALPHA 1,2 MANNOSIDASE AND CULTURE METHODS THEREOF 01-27-2011
6. 20110008375 Uses of Myostatin Antagonists - methods for treating disorders arising from hypogonadism rheumatoid cachexia 01-13-2011
7. 20110003755 Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof 01-06-2011
8. 20100331548 SOLID-STATE FORM OF AMG 706 AND PHARMACEUTICAL COMPOSITIONS THEREOF 12-30-2010
9. 20100331526 CAPTURE PURIFICATION PROCESSES FOR PROTEINS EXPRESSED IN A NON-MAMMALIAN SYSTEM 12-30-2010
10. 20100331306 HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them for the treatment of general inflammation 12-30-2010
11. 20100331293 HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them for the treatment of general inflammation 12-30-2010
12. 20100324269 REFOLDING PROTEINS USING A CHEMICALLY CONTROLLED REDOX STATE 12-23-2010
13. 20100324047 RAF KINASE MODULATORS AND METHODS OF USE 12-23-2010
14. 20100323954 CHIMERIC POLYPEPTIDES AND USES THEREOF - The disclosure provides nucleic acid molecules encoding chimeric polypeptides chimeric polypeptides 12-23-2010
15. 20100317668 SUBSTITUTED PYRANO [2,3-B] PYRIDINAMINE COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE 12-16-2010
16. 20100316593 Pharmaceutical Formulations - method of stabilizing an aqueous protein or antibody formulation is disclosed herein 12-16-2010
17. 20100311953 PROCESS FOR PURIFYING PROTEINS - process for purifying a protein by mixing a protein preparation with a solution having a first salt and a second salt 12-09-2010
18. 20100305307 HUMAN MONOCLONAL ANTIBODIES TO EPIDERMAL GROWTH FACTOR RECEPTOR 12-02-2010
19. 20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra 12-02-2010
20. 20100298367 Conformationally Constrained Carboxylic Acid Derivatives Useful for Treating Metabolic Disorders 11-25-2010
21. 20100298229 OSTEOPROTEGERIN - novel secreted polypeptide termed osteoprotegerin which is a member of the tumor necrosis factor receptor superfamily and is involved 11-25-2010
22. 20100297668 HUMAN E3ALPHA UBIQUITIN LIGASE FAMILY - novel polypeptide encoding a protein which is the full length human ortholog of E3 11-25-2010
23. 20100292234 TRIAZOLE FUSED HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF 11-18-2010
24. 20100286060 SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOEITIN-2 11-11-2010
25. 20100285131 FGF21 MUTANTS AND USES THEREOF - The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides FGF21 mutant polypeptides 11-11-2010
26. 20100280008 AURORA KINASE MODULATORS AND METHOD OF USE 11-04-2010
27. 20100279323 METHOD FOR PREDICTING RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR-DIRECTED THERAPY 11-04-2010
28. 20100273764 INHIBITORS OF PI3 KINASE AND/OR MTOR - compounds of Formula I or a pharmaceutically acceptable salt thereof 10-28-2010
29. 20100261728 TRP-M8 RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS 10-14-2010
30. 20100255537 NUCLEIC ACID MOLECULES ENCODING BETA-LIKE GLYCOPROTEIN HORMONE POLYPEPTIDE AND HETERODIMER THEREOF 10-07-2010
31. 20100249102 Heterotricyclic Metalloprotease Inhibitors 09-30-2010
32. 20100240582 Peptides and related molecules that modulate nerve growth factor activity 09-23-2010
33. 20100234373 BIS-ARYL AMIDE COMPOUNDS AND METHODS OF USE 09-16-2010
34. 20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides 09-16-2010
35. 20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides 09-09-2010
36. 20100222338 BETA-SECRETASE MODULATORS AND METHODS OF USE 09-02-2010
37. 20100203610 METHODS OF TREATING CELL CULTURE MEDIA FOR USE IN A BIOREACTOR 08-12-2010
38. 20100183616 Antibodies against interleukin-1 beta - Antibodies directed to the antigen IL-1 07-22-2010
39. 20100179177 HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them for the treatment of general inflammation 07-15-2010
40. 20100173418 Polypeptides with Reduced Susceptibility to Oxidation and Methods of Making 07-08-2010
41. 20100160312 Substituted Pyridone Compounds and Methods of Use 06-24-2010
42. 20100160283 HETEROARYL-SUBSTITUTED ALKYNE COMPOUNDS AND METHOD OF USE 06-24-2010
43. 20100160280 AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS 06-24-2010
44. 20100158908 Stable Polypeptide Formulations - formulation including a buffer having a pH less than 6 06-24-2010
45. 20100137323 BENZO-FUSED COMPOUNDS FOR USE IN TREATING METABOLIC DISORDERS 06-03-2010
46. 20100137278 PYRAZINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS 06-03-2010
47. 20100130727 Methods and Systems for Isolating Target Molecules from Complex Solutions by Column-Chromatography Using Eluants Containing Organic Solvents 05-27-2010
48. 20100125074 Thieno-[2,3-d]Pyrimidine and Thieno-Pyridazine Compounds and Methods of Use 05-20-2010
49. 20100125062 PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS 05-20-2010
50. 20100120774 Substituted Pyrano [2,3-b] Pyridinamine compounds as beta-secretase modulators and methods of use 05-13-2010
51. 20100087429 SPIRO-TRICYCLIC RING COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE 04-08-2010
52. 20100087420 Heterotricyclic Metalloprotease Inhibitors 04-08-2010
53. 20100075974 HETEROCYCLIC GPR40 MODULATORS - compounds useful, for example, for treating metabolic disorders in a subject 03-25-2010
54. 20100074909 Combinations for the treatment of cancer 03-25-2010
55. 20100056765 Formulations That Inhibit Protein Aggregation 03-04-2010
56. 20100048572 NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF 02-25-2010
57. 20100010014 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE 01-14-2010
58. 20090325880 TNF RECEPTOR-LIKE MOLECULES AND USES THEREOF 12-31-2009
59. 20090318341 Methods of using OSK1 peptide analogs - composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable 12-24-2009
60. 20090312433 TREATMENT OF VR1-ANTAGONIST-INDUCED INCREASE IN BODY TEMPERATURE WITH AN ANTIPYRETIC AGENT 12-17-2009
61. 20090305986 FGF21 Mutants and uses thereof - The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides FGF21 mutant polypeptides 12-10-2009
62. 20090305399 DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression 12-10-2009
63. 20090299044 DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression 12-03-2009
64. 20090298836 Thiadiazole modulators of PKB - thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein 12-03-2009
65. 20090297520 Methods of using conjugated toxin peptide therapeutic agents 12-03-2009
66. 20090291885 Conjugated toxin peptide therapeutic agents 11-26-2009
67. 20090286964 Modified Fc molecules - The present invention concerns compositions of matter for example but not limited to 11-19-2009
68. 20090281286 Modified Fc molecules - The present invention concerns compositions of matter for example but not limited to 11-12-2009
69. 20090281028 OSK1 peptide analogs and pharmaceutical compositions 11-12-2009
70. 20090275602 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use 11-05-2009
71. 20090275598 Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders 11-05-2009
72. 20090275592 Heterocyclic modulators of PKB - heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B 11-05-2009
73. 20090270445 Thiazole compounds and methods of use - methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases 10-29-2009
74. 20090264424 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS 10-22-2009
75. 20090258017 Lyophilized therapeutic peptibody Formulations 10-15-2009
76. 20090252703 Use of alcohol co-solvents to improve pegylation reaction yields 10-08-2009
77. 20090234104 Modified Fc molecules - The present invention concerns compositions of matter for example but not limited to 09-17-2009
78. 20090221789 Crystalline Polypeptides - Crystalline formulations of therapeutic peptides, along with methods for making and using the same, are provided 09-03-2009
79. 20090208504 Polypeptides involved in immune response 08-20-2009
80. 20090203609 Use of IL-1 inhibitors for treating IL-1 mediated diseases 08-13-2009
81. 20090197879 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS 08-06-2009
82. 20090163501 Aurora kinase modulators and method of use 06-25-2009
83. 20090163489 Inhibitors of PI3 kinase - compounds of Formula I or a pharmaceutically acceptable salt thereof 06-25-2009
84. 20090156633 Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity 06-18-2009
85. 20090156605 Quinolones and azaquinolones that inhbit prolyl hydroxylase 06-18-2009
86. 20090149468 Substituted heterocyclic compounds and methods of use 06-11-2009
87. 20090143575 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS 06-04-2009
88. 20090143355 Substituted aryl-amine derivatives and methods of use 06-04-2009
89. 20090137582 Pyrazolo-pyridinone derivatives and methods of use 05-28-2009
90. 20090137581 Heterocyclic compounds and their uses - Substituted bicyclic heteroaryls and compositions containing them for the treatment of general inflammation 05-28-2009
91. 20090137561 Substituted biphenyl GPR40 modulators - compounds useful, for example, for treating metabolic disorders in a subject 05-28-2009
92. 20090137547 Heterobicyclic metalloprotease inhibitors 05-28-2009
93. 20090137483 Antagonists of the bradykinin B1 receptor 05-28-2009
94. 20090137452 Antagonists of the bradykinin B1 receptor 05-28-2009
95. 20090130114 WISE BINDING AGENTS AND EPITOPES - binding agents for WISE, and includes for their manufacture and use 05-21-2009
96. 20090118181 Compositions and methods for producing bioactive fusion proteins 05-07-2009
97. 20090111859 Substituted biphenyl GPR40 modulators - compounds useful, for example, for treating metabolic disorders in a subject 04-30-2009
98. 20090111806 Azaquinolone based compounds exhibiting prolyl hydroxylase Inhibitory activity, compositions, and uses thereof 04-30-2009
99. 20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity 04-16-2009
100. 20090093483 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof 04-09-2009
101. 20090088475 Indanone derivatives that inhibit prolyl hydroxylase 04-02-2009
102. 20090082358 Vanilloid receptor ligands and their use in treatments 03-26-2009
103. 20090069297 Aurora kinase modulators and method of use 03-12-2009
104. 20090054405 PI3 kinase modulators and methods of use 02-26-2009
105. 20090048149 Antagonists of the bradykinin B1 receptor 02-19-2009
106. 20090041768 Modified Fc molecules - The present invention concerns compositions of matter for example but not limited to 02-12-2009
107. 20090036478 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use 02-05-2009
108. 20090030005 Combinations for the treatment of cancer 01-29-2009
109. 20090030002 Heterocyclic compounds and their uses - Substituted bicyclic heteroaryls and compositions containing them for the treatment of general inflammation 01-29-2009
110. 20090023761 Heterocyclic compounds and their uses - Substituted bicyclic heteroaryls and compositions containing them for the treatment of general inflammation 01-22-2009
111. 20090023636 Methods and compositions for the prevention and treatment of anemia 01-22-2009
112. 20090022744 Modified Fc molecules - The present invention concerns compositions of matter for example but not limited to 01-22-2009
113. 20090017137 Methods and compositions for the prevention and treatment of anemia 01-15-2009
114. 20090012299 Pyrazolo-pyridinone compounds and methods of use thereof 01-08-2009
115. 20090012272 Modified Fc molecules - The present invention concerns compositions of matter for example but not limited to 01-08-2009
116. 20090011497 Peptides and related compounds having thrombopoietic activity 01-08-2009
117. 20080318946 Di-amino-substituted heterocyclic compounds and methods of use 12-25-2008
118. 20080269243 Thiadiazole compounds and methods of use 10-30-2008
119. 20080261968 Heterobicyclic metalloprotease inhibitors 10-23-2008
120. 20080255205 Multi-cyclic compounds and methods of use 10-16-2008
121. 20080255145 Thiadiazole compounds and methods of use 10-16-2008
122. 20080249090 Substituted pyridone compounds and methods of use 10-09-2008
123. 20080241096 IL-1 family variants - compositions and methods relating to IL-1Rrp2 requiring proteins 10-02-2008
124. 20080227779 Heterocyclic compounds and methods of use 09-18-2008
125. 20080221128 Metalloprotease inhibitors containing a squaramide moiety 09-11-2008
126. 20080221095 Metalloprotease inhibitors containing a heterocyclic moiety 09-11-2008
127. 20080221094 Metalloprotease inhibitors containing a squaramide moiety 09-11-2008
128. 20080221093 Metalloprotease inhibitors containing a heterocyclic moiety 09-11-2008
129. 20080221092 Heterobicyclic metalloprotease inhibitors 09-11-2008
130. 20080221091 Metalloprotease inhibitors containing a heterocyclic moiety 09-11-2008
131. 20080221083 Heterobicyclic metalloprotease inhibitors 09-11-2008
132. 20080214795 Method of isolating antibodies by precipitation 09-04-2008
133. 20080213282 Formulations - formulation comprising a buffer with a pH from about 4 09-04-2008
134. 20080207607 Heterotricyclic metalloprotease inhibitors 08-28-2008